Clinical trial · Interventional
The Effect of Natural Molecules on HPV Infection
Counteracting HPV Infection with Natural Molecules
NCT06661083CI-TRIAL-00087382completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to evaluate the effect of the administration of natural molecules in the treatment of HPV infection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HPV (Human Papillomavirus)-associated | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EGCG, FA, HA, B12 | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Patients with HPV infection
- interventionNames
- Dietary Supplement: EGCG, FA, HA, B12
Primary outcomes (1)
- measure
- HPV DNA test negativity
- timeFrame
- 6 months of treatment
- description
- Percentage
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * HPV DNA test positivity * over 18 years Exclusion Criteria: * pregnancy * breastfeeding * assumption of other products containing EGCG or green tea * primary immunodepression or pharmacological induced one
References
Publications (0)
Data not yet available
No reference posted for this study.